top of page

Rise Against Cancer: New Mobile App Empowers Individuals in India's Fight Against Cancer

On World Cancer Day, a beacon of hope emerged in India with the launch of the Rise Against Cancer mobile app. This collaborative effort by the Indian Cancer Society (ICS), Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), and Roche Products (India) aims to tackle the daunting challenge of cancer awareness in a country where an estimated 1.3 million new cases are diagnosed every year.

More Than Just an App: A Comprehensive Resource

Rise Against Cancer transcends the definition of a simple app. It serves as a multilingual, one-stop platform designed to empower individuals with the knowledge and resources needed to navigate their cancer journey effectively. Whether you're a patient, survivor, caregiver, or someone simply seeking information, this app aims to be your guiding light.

Features for Everyone:

  • Awareness: Gain insights into various cancer types, their early signs and symptoms, and dispel common myths surrounding the disease.

  • Knowledge Sharing: Connect with a community of patients, survivors, and caregivers for peer support and exchange valuable experiences.

  • End-to-End Guidance: Access information on screening, treatment options, financial assistance, and overall health and wellness resources throughout your cancer journey.

  • Multilingual Accessibility: Break down language barriers and access information in your preferred language, ensuring inclusivity for diverse communities .

A Collaborative Effort, A Nationwide Impact:

This initiative embodies the power of collaboration in tackling a formidable foe like cancer. The combined expertise of ICS, RGCIRC, and Roche Products has resulted in a valuable tool that has the potential to impact millions of lives across India.

Empowering individuals with knowledge is the first step towards winning the fight against cancer. The Rise Against Cancer app is a significant step in that direction, offering hope and support to those affected by this disease.


Comments


bottom of page